dc.creator | Sourlas, V. | en |
dc.creator | Athanasiou, V. | en |
dc.creator | Vasilaki, A. | en |
dc.date.accessioned | 2015-11-23T10:47:59Z | |
dc.date.available | 2015-11-23T10:47:59Z | |
dc.date.issued | 2008 | |
dc.identifier.issn | 10116583 | |
dc.identifier.uri | http://hdl.handle.net/11615/33211 | |
dc.description.abstract | The modulation of the enhanced release of [3H]-D-Aspartate and [3H]GABA following ischemia-like conditions was studied in rat retinal and hippocampal preparations using a superfusion system. Ischemia was simulated by a glucose-free medium equilibrated with 95%N2/5%CO 2. In this model the potential neuroprotective effect somatostatin on [3H]-D-Aspartate and [3H]GABA release induced by ischemia-like conditions were investigated. Retina was more resistant to ischemia compared to hippocampus. Somatostatin (SRIF-14) decreased ischemia-induced [3H]GABA release in both retina and hippocampus while the the sst2/5 somatostatin receptor selective agonist Octreotide decreased and the sst2 somatostatin receptor selective antagonist D-Tyr8 CYN 154806 increased the ischemia-induced [ 3H]-D-Aspartate from both retinal and hippocampal preparations indicating that endogenous somatostatin plays a neuroprotective role in both tissues through sst2 receptor activation, at least as far as the ischemia-induced [3H]-D-Aspartate release is concerned. ©PHARMAKON-Press. | en |
dc.source | Review of Clinical Pharmacology and Pharmacokinetics, International Edition | en |
dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-45149108871&partnerID=40&md5=8222394a346a6e2e12af3e7c428e49fc | |
dc.subject | Hippocampus | en |
dc.subject | In vitro ischemia | en |
dc.subject | Retina | en |
dc.subject | Somatostatin | en |
dc.subject | Superfusion | en |
dc.subject | 4 aminobutyric acid | en |
dc.subject | agents interacting with transmitter, hormone or drug receptors | en |
dc.subject | ch 275 | en |
dc.subject | cyn 154806 | en |
dc.subject | dextro aspartic acid | en |
dc.subject | octreotide | en |
dc.subject | receptor blocking agent | en |
dc.subject | somatostatin 14 | en |
dc.subject | somatostatin receptor | en |
dc.subject | somatostatin[8 dextro tryptophan] | en |
dc.subject | srif 14 | en |
dc.subject | 4 aminobutyric acid release | en |
dc.subject | animal experiment | en |
dc.subject | animal model | en |
dc.subject | animal tissue | en |
dc.subject | conference paper | en |
dc.subject | controlled study | en |
dc.subject | drug effect | en |
dc.subject | in vitro study | en |
dc.subject | ischemia | en |
dc.subject | neuroprotection | en |
dc.subject | neurosecretion | en |
dc.subject | nonhuman | en |
dc.subject | rat | en |
dc.title | Effect of somatostatinergic analogues on the ischemia-induced release of [3H]-D-aspartate and [3H]-GABA from rat retina and hippocampus | en |
dc.type | journalArticle | en |